中国伤残医学
中國傷殘醫學
중국상잔의학
CHINESE JOURNAL OF TRAUMA AND DISABILITY MEDICINE
2014年
8期
8-10
,共3页
厄贝沙坦%苯磺酸氨氯地平片%高血压
阨貝沙坦%苯磺痠氨氯地平片%高血壓
액패사탄%분광산안록지평편%고혈압
Irbesartan%Amlodipine besylate tablets%Hypertension
目的:探究厄贝沙坦联合苯磺酸氨氯地平片治疗高血压的临床疗效。方法:对照组单纯给予厄贝沙坦治疗,观察组在此基础上联合苯磺酸氨氯地平片治疗,观察对比2组临床疗效及治疗前后血压控制情况。结果:观察组总有效率为92.86%,明显高于对照组的71.43%,2组比较差异具有统计学意义,P<0.05;2组患者治疗后的血压均有不同程度降低,且观察组治疗后血压下降程度,明显大于对照组,2组比较差异具有统计学意义,P<0.05;2组患者用药后,均未出现严重不良反应。结论:2药联合治疗高血压较单一用药的临床疗效更为确切,用药24内可平缓稳定地控制血压,进而有效保护靶器官,且用药安全,值得临床应用和推广。
目的:探究阨貝沙坦聯閤苯磺痠氨氯地平片治療高血壓的臨床療效。方法:對照組單純給予阨貝沙坦治療,觀察組在此基礎上聯閤苯磺痠氨氯地平片治療,觀察對比2組臨床療效及治療前後血壓控製情況。結果:觀察組總有效率為92.86%,明顯高于對照組的71.43%,2組比較差異具有統計學意義,P<0.05;2組患者治療後的血壓均有不同程度降低,且觀察組治療後血壓下降程度,明顯大于對照組,2組比較差異具有統計學意義,P<0.05;2組患者用藥後,均未齣現嚴重不良反應。結論:2藥聯閤治療高血壓較單一用藥的臨床療效更為確切,用藥24內可平緩穩定地控製血壓,進而有效保護靶器官,且用藥安全,值得臨床應用和推廣。
목적:탐구액패사탄연합분광산안록지평편치료고혈압적림상료효。방법:대조조단순급여액패사탄치료,관찰조재차기출상연합분광산안록지평편치료,관찰대비2조림상료효급치료전후혈압공제정황。결과:관찰조총유효솔위92.86%,명현고우대조조적71.43%,2조비교차이구유통계학의의,P<0.05;2조환자치료후적혈압균유불동정도강저,차관찰조치료후혈압하강정도,명현대우대조조,2조비교차이구유통계학의의,P<0.05;2조환자용약후,균미출현엄중불량반응。결론:2약연합치료고혈압교단일용약적림상료효경위학절,용약24내가평완은정지공제혈압,진이유효보호파기관,차용약안전,치득림상응용화추엄。
Objective:To explore the irbesartan amlodipine besylate tablets combined clinical efficacy of the treatment of hypertension . Methods:The control group was given irbesartan treatment , observation group on the basis of combined amlodipine besylate tablets treat -ment,observation and comparison of clinical efficacy in blood pressure before and after treatment .Methods:The control group was givenirbesartan treatment, observation group on the basisof combined amlodipine besylate tablets treatment , observation and comparison of clinicalefficacy after treatment blood pressure control .Results:The total effective rate was 92.86%, significantly higher than 71.43%, thedifference was statistically significant, P <0.05; blood pressure after two groups of patients were reduced to varying degrees , and the observationgroup After a drop of blood, significantly higher than the control group, the difference was statistically significant, P <0.05;two groups of patients after treatment, No serious adverse reactions.Conclusion:The clinical efficacy of two -drug combination therapy ofhypertension should be more precise than a single drug , medication may be flat and stable control of blood pressure in 24, thus effectivelyprotecting target organs, and drug safety, worthy of clinical application and promotion .